Financial

Ryght and University of Adelaide Announce Strategic Partnership at BIO

The collaboration will help establish South Australia as a global leader in AI and biotechnology. LAGUNA BEACH, Calif., June 4,…

1 month ago

Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery

Predictive Oncology’s organ-specific in vitro models are designed to better mimic the physiological environment of human tissue The 3D cell culture…

1 month ago

Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance

-Business performance on track to achieve approximately $20 million of annualized run-rate EBITDASO1 on annualized revenues of approximately $75 million…

2 months ago

GE HealthCare Tops List for Third Year in a Row with Highest Number of AI-Enabled Medical Device Authorizations

FDA’s list of AI-enabled device authorizations includes more than 850 devices; 72 are from GE HealthCare – more than any…

2 months ago

HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

New Data Presented at Heart Rhythm Society Conference Demonstrates Continued Progress with Company’s AI Program Data Show That Applying AI…

2 months ago

Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial

Mainz Biomed Presented Industry Leading Results: 97% Sensitivity for Colorectal Cancer, 82% for Advanced Precancerous Lesions The eAArly DETECT results…

2 months ago

AI/ML Innovations Inc. Announces Agreement with Moonshot Inc.

TORONTO, ON / ACCESSWIRE / May 17, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to…

2 months ago

FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization

First-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patientsManassas, Virginia--(Newsfile Corp. -…

2 months ago

Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development

NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Turbine, a predictive simulation company that…

2 months ago

Element Science Appoints Lee Smith, Jr. as the Company’s First Head of Commercial

Mr. Smith brings 20 years of successful leadership experience in Sales, Commercial Operations, and Customer SuccessSAN FRANCISCO--(BUSINESS WIRE)--Element Science, an…

2 months ago